Cell-Penetrating Peptide-Inspired Chitosan Improves Lung Delivery of Cancer Drug Octreotide

Chitosan modified with amino acids mimicking cell-penetrating peptides enhanced octreotide absorption across lung epithelial cells in both lab and rat models.

Qin, Lu et al.·Carbohydrate polymers·2025·low-moderateAnimal StudyAnimal Study
RPEP-13145Animal Studylow-moderate2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
low-moderate
Sample
N=Not specified (animal study)
Participants
Sprague Dawley rats and lung epithelial cell models

What This Study Found

Amino acid-modified chitosan enhanced octreotide absorption across lung epithelium in an amino acid type-dependent manner in cells and rats.

Key Numbers

Arginine-chitosan showed highest absorption enhancement among tested AA-CSs; tested in 3D Transwell models and Sprague Dawley rats.

How They Did This

Synthesis of amino acid-chitosan copolymers, 3D Transwell cell models, and Sprague Dawley rat lung delivery studies.

Why This Research Matters

Inhaled peptide drugs could replace injections for conditions like neuroendocrine tumors, improving patient compliance and quality of life.

The Bigger Picture

CPP-inspired delivery materials could enable inhaled administration of many peptide drugs currently limited to injection.

What This Study Doesn't Tell Us

Rat lung physiology differs from human. Long-term safety of modified chitosan in lungs needs assessment.

Questions This Raises

  • ?Which amino acid modification provides the best safety-efficacy balance?
  • ?Could this approach work for inhaled GLP-1 or insulin delivery?

Trust & Context

Key Stat:
AA-dependent Amino acid type on chitosan determined the extent of octreotide absorption enhancement across lung epithelium
Evidence Grade:
Preclinical drug delivery study with both in vitro and in vivo components — promising but needs human translation.
Study Age:
Published in 2025, advancing inhaled peptide delivery technology.
Original Title:
Biomimetic chitosan derivatives inspired by cell-penetrating peptides for enhanced octreotide absorption following lung delivery.
Published In:
Carbohydrate polymers, 369, 124251 (2025)
Database ID:
RPEP-13145

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Could octreotide be inhaled instead of injected?

This study shows modified chitosan polymers can help octreotide cross lung tissue — a step toward inhaled delivery replacing injections.

What are cell-penetrating peptides?

Short peptides that can cross cell membranes — their design principles were used to modify chitosan for better drug delivery through the lungs.

Read More on RethinkPeptides

Cite This Study

RPEP-13145·https://rethinkpeptides.com/research/RPEP-13145

APA

Qin, Lu; Cui, Zhixiang; Zhang, Ziwei; Zhai, Qiyao; Wu, Yu; Guan, Jian; Xu, Enyu; Zhang, Xin; Mao, Shirui. (2025). Biomimetic chitosan derivatives inspired by cell-penetrating peptides for enhanced octreotide absorption following lung delivery.. Carbohydrate polymers, 369, 124251. https://doi.org/10.1016/j.carbpol.2025.124251

MLA

Qin, Lu, et al. "Biomimetic chitosan derivatives inspired by cell-penetrating peptides for enhanced octreotide absorption following lung delivery.." Carbohydrate polymers, 2025. https://doi.org/10.1016/j.carbpol.2025.124251

RethinkPeptides

RethinkPeptides Research Database. "Biomimetic chitosan derivatives inspired by cell-penetrating..." RPEP-13145. Retrieved from https://rethinkpeptides.com/research/qin-2025-biomimetic-chitosan-derivatives-inspired

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.